Investor webinar: Neuren continues PMS Phase 3 preparations following positive FDA meeting  
 
    Investor roadshow presentation, 19 August 2024  
 
    Investor webinar: NNZ-2591 Angelman syndrome Phase 2 trial top-line results  
 
    NNZ-2591 Angelman top-line results presentation  
 
    Corporate Presentation, 29 May 2024  
 
    AGM webcast, 28 May 2024  
 
    AGM Chair Address & CEO Presentation  
 
    Investor webinar - Pitt Hopkins Phase 2 results, 27 May 2024  
 
    Pitt Hopkins Phase 2 results presentation, 27 May 2024  
 
    Investor presentation, 15 May 2024  
 
    Investor webinar, 29 February 2024  
 
    Investor web conference, 18 December 2023  
 
    Investor presentation, 18 December 2023  
 
    Investor presentation, 8 November 2023  
 
    Investor web conference, 28 August 2023  
 
    Investor presentation, 28 August 2023  
 
    Investor web conference, 14 July 2023  
 
    Jefferies Global Healthcare Conference, 8 June 2023  
 
    AGM webcast, 30 May 2023  
 
    AGM Chair Address & CEO Presentation  
 
    Investor webinar, 14 March 2023  
 
    MST Financial: Late Stage Biotech Forum, 30 Nov 2022  
 
    Bell Potter Healthcare Conference, 8 Nov 2022  
 
    AGM Chairman's Address & CEO Presentation  
 
    Investor webinar, 25 February 2022  
 
    MST Access Australian Micro & Small Caps Conference 2021 15 June 2021